21. ISAM-Congress

Santa Fe, NM

03rd - 07th June 2017

  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • >
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • speakers
  • society
  • culture
  • history

The International Society for Aerosols in Medicine (ISAM) was founded in 1970. The objectives of ISAM are to stimulate and further the interdisciplinary cooperation and exchange of information in all aspects of aerosol research in medicine including health effects of inhaled aerosols and pulmonary drug delivery.

visit homepage

Speakers

 

The main topics/sessions and invited speakers are as follows

 

  • State of the Art for Aerosols in Asthma and COPD
    Monica Kraft (University of Arizona, Tucson)
    M.B. Drummond (University of Carolina, Chapel Hill)
  • Idiopathic pulmonary fibrosis
    Jeremy Brower (Lovelace Respiratory Research Institute)
    David Schwartz (University of Colorado)
  • Through the nose, for the nose, by the nose: the nasal route of aerosol delivery
    Julie Kimbel (University of Carolina, Chapel Hill)
    Ronan Mac Loughlin (Aerogen)
  • Advanced in vitro Lung Models
    Dan Huh (University of Pennsylvania. Philadelphia)
  • Lung models - relevance for human inhalation
    Jan De Backer (FluidDA)
    Jose Venegas  (Mass General Hospital, Harvard)
  • Formulation development, device resistance and airway targeting with dry powder inhalers
    Jeff Weers (Novartis)
    Mark Everard ((University of Western Australia, Perth)
  • Pulmonary Delivery of Therapeutic and Diagnostic Gases
    Warren Zapol (Mass General Hospital, Harvard)
    Cecil Charles (Duke University)
  • Advancements in Treating Pulmonary Infections
    Samati Nambiar (FDA)
    Gregory Tino (U Penn, Phildelphia) (tentative)
  • Pro-Con debate:  Will personalized medicine decrease the relevance of aerosol therapy?
    Peter Le Souef (University of Western Australia, Perth)
    Chris O’Callaghan (University College London, UK)
  • E-cigarettes and alternative delivery devices
    Phil Kuehl ((Lovelace Respiratory Research Institute)
  • New and emerging therapeutic aerosols and delivery systems